Table 3.
Summary of cell-type specificity of kinases in neuritogenesis and regeneration
| Primary cortical neurons | Primary hippocampal neurons | Primary dopaminergic neurons | Neuroblastoma cells | PC12 cells | Spiral ganglion neurons | Dorsal root ganglion neurons | Conclusion | Citations | |
|---|---|---|---|---|---|---|---|---|---|
| Akt | N/A | (+) elongation | N/A | N/A | (+) elongation | (+) initiation | (+) elongation | Cell type specific | [94–96, 114] |
| (-) elongation | (+) regeneration | ||||||||
| AMPK | (+) elongation | (−) elongation | (−) elongation | N/A | N/A | N/A | N/A | Cell type specific, subunit composition specific | [70–79] |
| (−) elongation | (−) initiation | ||||||||
| Aurora kinase A | (+) elongation | N/A | N/A | N/A | N/A | N/A | (+) elongation | Not cell type specific | [98] |
| CaMK II | N/A | (+) elongation | N/A | (+) initiation | N/A | N/A | N/A | Cell-type specific | [46, 71] |
| (+) elongation | |||||||||
| Cdk5 | (+) elongation | N/A | N/A | N/A | N/A | N/A | N/A | More studies in different model systems must be performed | [99–101] |
| FAK | (+) initiation | (+) initiation | N/A | N/A | N/A | N/A | N/A | Not cell type specific | [53, 54] |
| JNK | N/A | N/A | N/A | N/A | N/A | (+) initiation | (+) initiation | Cell-type specific, isoform-type specific, pathway specific | [68–70] |
| (+) regeneration | |||||||||
| (−) initiation | |||||||||
| MAPK/ERK | N/A | (+) initiation | N/A | (+) initiation | (+) initiation | N/A | (+) regeneration | Cell type specific | [22, 63–65, 114] |
| (+) elongation | |||||||||
| (+) elongation | |||||||||
| mTOR | N/A | (+) elongation | N/A | N/A | N/A | N/A | (+) regeneration | More studies in different model systems must be performed | [94, 114] |
| PI3K | N/A | N/A | N/A | N/A | (+) initiation | (+) initiation | (+) initiation | Not cell type specific | [85–87, 114] |
| (+) regeneration | |||||||||
| PKA | N/A | N/A | N/A | (+) initiation | N/A | (+) elongation | N/A | Cell type specific | [56, 57, 111, 112] |
| (−) elongation | |||||||||
| (+) regeneration | |||||||||
| PKC | N/A | N/A | N/A | (−) initiation | N/A | N/A | N/A | More studies in different model systems must be performed | [56, 58, 59] |
| Rho kinase | (+) elongation | N/A | N/A | N/A | (+) elongation | N/A | N/A | Dose dependent* | [93, 102–104, 113] |
| (−) elongation | |||||||||
| (−) regeneration | |||||||||
| (−) elongation |
Kinases are designated as cell-type specific if they either produce opposite or additional effects in different model systems
N/A not assessed, (+) elongation/initiation/regeneration positive effector of neurite elongation, initiation, or regeneration, (−) elongation/initiation/regeneration inhibits neurite elongation, initiation, or regeneration
*Rho kinase is designated as “dose dependent” because depending on the level of inhibition used it produces different effects on neurite formation in multiple cell types